Gilead to make remdesivir coronavirus treatment in 127 countries

Gilead has struck a licensing agreement with five generic drugmakers around the globe

• deal is to make antiviral drug remdesivir in 127 countries
• deal is "royalty-free" until WHO says the Covid-19 outbreak is no longer a global health crisis or "until a pharmaceutical product other than remdesivir or a vaccine is approved to treat or prevent Covid-19."

Back in mid-April I posted the breaking the news on this:

• Early data on Gilead coronavirus medicine remdesivir is very encouraging

The news prompted swings not only in stocks but also in other markets (FX of course) . Since then there have been various updates, it works, it doesn't, the usual. Much of of it ill-informed (again, the usual).

Anyway, the latest is this licensing agreement for the drug. Beats drinking bleach I guess.

Via CNBC

Here you go, the recipe! (via Wikipedia if memory serves)